No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3ozqA, 1.0000, 0.00, 1.000, 364, 361, CRYSTAL STRUCTURE OF SERPIN48 WHICH IS A HIGHLY SPECIFIC SERPIN IN THE INSECT TENEBRIO MOLITOR
2, 1azxI, 0.9267, 2.08, 0.279, 417, 359, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
3, 1sekA, 0.9258, 1.89, 0.322, 376, 354, THE STRUCTURE OF ACTIVE SERPIN K FROM MANDUCA SEXTA AND A MODEL FOR SERPIN-PROTEASE COMPLEX FORMATION
4, 3f1sA, 0.9249, 1.97, 0.258, 385, 353, CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR
5, 1k9oI, 0.9240, 1.93, 0.336, 376, 354, CRYSTAL STRUCTURE OF MICHAELIS SERPIN-TRYPSIN COMPLEX
6, 3h5cA, 0.9239, 1.96, 0.258, 384, 356, X-RAY STRUCTURE OF PROTEIN Z-PROTEIN Z INHIBITOR COMPLEX
7, 1e03I, 0.9236, 2.13, 0.279, 418, 359, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
8, 1e04I, 0.9235, 2.19, 0.284, 403, 359, PLASMA BETA ANTITHROMBIN-III
9, 2antI, 0.9223, 2.17, 0.284, 419, 359, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
10, 2hijI, 0.9222, 2.17, 0.279, 411, 358, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
11, 1e05I, 0.9222, 2.18, 0.284, 417, 359, PLASMA ALPHA ANTITHROMBIN-III
12, 1nq9I, 0.9219, 1.96, 0.285, 406, 355, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
13, 1athA, 0.9215, 2.13, 0.282, 389, 358, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
14, 4x30A, 0.9214, 2.01, 0.256, 372, 356, CRYSTAL STRUCTURE OF HUMAN THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROINE AT 1.55 ANGSTROM RESOLUTION
15, 2behI, 0.9207, 2.02, 0.287, 413, 356, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
16, 2b4xI, 0.9185, 2.02, 0.282, 413, 355, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
17, 1tb6I, 0.9183, 2.01, 0.274, 412, 354, 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX
18, 1oyhI, 0.9177, 2.24, 0.279, 416, 359, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
19, 1dzhI, 0.9174, 2.20, 0.285, 417, 358, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
20, 2gd4I, 0.9164, 2.12, 0.274, 417, 354, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
21, 2gd4C, 0.9146, 2.19, 0.274, 418, 354, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
22, 3evjI, 0.9145, 2.02, 0.286, 404, 353, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
23, 3kcgI, 0.9139, 2.09, 0.275, 419, 353, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA- PENTASACCHARIDE COMPLEX
24, 1dzgI, 0.9126, 2.29, 0.284, 422, 359, N135Q-S380C-ANTITHROMBIN-III
25, 4dy7C, 0.9107, 2.13, 0.281, 377, 352, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
26, 1jmjB, 0.9106, 2.20, 0.259, 387, 355, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
27, 1antI, 0.9103, 2.09, 0.271, 402, 354, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
28, 1ovaA, 0.9098, 1.97, 0.274, 383, 350, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
29, 1yxaA, 0.9097, 2.03, 0.312, 372, 349, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
30, 2zv6B, 0.9095, 2.05, 0.312, 371, 349, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
31, 1jmjA, 0.9095, 2.21, 0.256, 397, 355, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
32, 2h4rA, 0.9092, 2.00, 0.333, 371, 351, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE NATIVE CONFORMATION
33, 1yxaB, 0.9089, 2.15, 0.311, 368, 351, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
34, 1ovaD, 0.9089, 2.08, 0.276, 385, 351, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
35, 4dy7F, 0.9075, 2.16, 0.288, 378, 351, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
36, 1ovaB, 0.9074, 2.12, 0.276, 371, 351, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
37, 3pzfA, 0.9069, 2.19, 0.279, 369, 351, 1.75A RESOLUTION STRUCTURE OF SERPIN-2 FROM ANOPHELES GAMBIAE
38, 4ga7A, 0.9060, 1.86, 0.335, 369, 346, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
39, 1t1fC, 0.9057, 2.25, 0.285, 419, 354, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
40, 1t1fB, 0.9057, 2.25, 0.285, 419, 354, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
41, 1t1fA, 0.9057, 2.25, 0.285, 419, 354, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
42, 1sr5A, 0.9055, 2.12, 0.277, 409, 350, ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE
43, 3r4lA, 0.9054, 2.29, 0.298, 377, 356, HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1
44, 5ncsA, 0.9049, 2.08, 0.261, 374, 348, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
45, 1ovaC, 0.9048, 1.94, 0.279, 373, 348, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
46, 2ceoA, 0.9042, 2.10, 0.260, 367, 350, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
47, 2ceoB, 0.9039, 2.10, 0.260, 367, 350, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
48, 5ncsB, 0.9037, 2.10, 0.261, 374, 348, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
49, 4y40A, 0.9033, 1.97, 0.236, 366, 347, STRUCTURE OF VASPIN MUTANT D305C V383C
50, 4roaA, 0.9033, 2.17, 0.275, 364, 349, 1.90A RESOLUTION STRUCTURE OF SRPN2 (S358W) FROM ANOPHELES GAMBIAE
51, 4ajtA, 0.9032, 2.14, 0.244, 372, 349, THE CRYSTAL STRUCTURE OF MOUSE PROTEIN-Z DEPENDENT PROTEASE INHIBITOR(MZPI)
52, 4dy0B, 0.9031, 2.13, 0.284, 370, 349, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
53, 1uhgD, 0.9030, 2.00, 0.279, 380, 348, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
54, 4if8A, 0.9020, 2.00, 0.236, 367, 347, STRUCTURE OF VASPIN
55, 1uhgB, 0.9019, 2.10, 0.275, 380, 349, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
56, 3le2A, 0.9017, 2.33, 0.261, 393, 353, STRUCTURE OF ARABIDOPSIS ATSERPIN1. NATIVE STRESSED CONFORMATION
57, 1ophA, 0.9015, 2.24, 0.291, 375, 351, NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN
58, 3ne4A, 0.9012, 2.18, 0.282, 370, 351, 1.8 ANGSTROM STRUCTURE OF INTACT NATIVE WILD-TYPE ALPHA-1-ANTITRYPSIN
59, 4ga7B, 0.9010, 1.84, 0.334, 367, 344, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
60, 1qlpA, 0.9009, 2.28, 0.276, 372, 352, 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS
61, 3f5nA, 0.9006, 2.02, 0.347, 364, 346, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
62, 4y3kA, 0.8996, 2.04, 0.236, 367, 347, STRUCTURE OF VASPIN MUTANT E379S
63, 5nbuA, 0.8995, 2.31, 0.287, 370, 352, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
64, 5hgcA, 0.8995, 2.29, 0.272, 373, 349, A SERPIN STRUCTURE
65, 1db2A, 0.8995, 2.45, 0.294, 377, 357, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
66, 1hp7A, 0.8993, 2.42, 0.288, 376, 354, A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENTER AND OTHER LOOPS
67, 1uhgC, 0.8992, 2.01, 0.282, 370, 347, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
68, 1oo8A, 0.8989, 2.28, 0.285, 370, 351, CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION
69, 1r1lI, 0.8980, 2.54, 0.281, 416, 359, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
70, 2zv6A, 0.8976, 1.58, 0.316, 350, 339, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
71, 2dutD, 0.8975, 2.00, 0.334, 366, 347, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
72, 2dutC, 0.8975, 2.00, 0.334, 366, 347, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
73, 2dutB, 0.8975, 2.00, 0.334, 366, 347, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
74, 2dutA, 0.8975, 2.00, 0.334, 366, 347, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
75, 1uhgA, 0.8975, 2.00, 0.286, 378, 346, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
76, 2qugA, 0.8971, 2.25, 0.280, 368, 350, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM A
77, 1lk6I, 0.8969, 2.37, 0.272, 410, 356, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
78, 3f5nD, 0.8965, 1.91, 0.344, 363, 343, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
79, 1psiA, 0.8965, 2.20, 0.286, 371, 350, INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU
80, 3cwlA, 0.8963, 2.30, 0.277, 371, 350, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM B
81, 2zv6C, 0.8962, 1.65, 0.316, 350, 339, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
82, 3cwmA, 0.8961, 2.18, 0.275, 369, 349, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN COMPLEXED WITH CITRATE
83, 1jvqI, 0.8959, 2.38, 0.272, 410, 356, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
84, 1br8I, 0.8934, 2.35, 0.274, 404, 354, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
85, 3druA, 0.8933, 2.13, 0.282, 363, 347, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
86, 4rsqK, 0.8932, 2.14, 0.270, 356, 344, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
87, 4p0oA, 0.8931, 2.26, 0.353, 371, 351, CLEAVED SERPIN 42DA
88, 2peeB, 0.8931, 2.30, 0.271, 387, 350, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
89, 3fgqB, 0.8930, 2.16, 0.339, 374, 348, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
90, 3fgqA, 0.8929, 2.16, 0.339, 374, 348, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
91, 4dy0A, 0.8928, 2.02, 0.288, 362, 344, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
92, 5cdxA, 0.8923, 1.91, 0.377, 353, 342, CRYSTAL STRUCTURE OF CONSERPIN
93, 2peeA, 0.8923, 2.31, 0.271, 387, 350, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
94, 3vvjC, 0.8919, 2.18, 0.301, 384, 349, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
95, 4robB, 0.8918, 2.14, 0.267, 356, 344, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
96, 5ce0B, 0.8916, 1.81, 0.374, 353, 340, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
97, 3druB, 0.8909, 2.18, 0.285, 362, 347, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
98, 3f5nB, 0.8907, 1.89, 0.352, 376, 341, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
99, 4rsqE, 0.8906, 2.29, 0.270, 356, 345, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
100, 5io1A, 0.8905, 2.31, 0.276, 365, 348, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
101, 3druC, 0.8903, 2.23, 0.282, 360, 347, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
102, 1jmoA, 0.8902, 2.29, 0.261, 425, 349, CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX
103, 5io1B, 0.8900, 2.34, 0.276, 364, 348, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
104, 4rsqH, 0.8894, 2.17, 0.271, 357, 343, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
105, 4if8B, 0.8894, 1.96, 0.237, 361, 342, STRUCTURE OF VASPIN
106, 5nbvA, 0.8889, 2.46, 0.286, 369, 350, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
107, 4rsqG, 0.8889, 2.21, 0.267, 357, 344, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
108, 3vvjA, 0.8889, 2.22, 0.304, 384, 349, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
109, 3vvjB, 0.8886, 2.22, 0.301, 384, 349, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
110, 4rsqA, 0.8884, 2.12, 0.272, 356, 342, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
111, 2b5tI, 0.8883, 2.50, 0.285, 415, 354, 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES
112, 4rsqL, 0.8882, 2.18, 0.265, 356, 343, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
113, 1attB, 0.8882, 2.32, 0.276, 410, 351, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
114, 4y40B, 0.8873, 1.95, 0.235, 361, 341, STRUCTURE OF VASPIN MUTANT D305C V383C
115, 3drmA, 0.8872, 2.11, 0.276, 362, 344, 2.2 ANGSTROM CRYSTAL STRUCTURE OF THR114PHE ALPHA1- ANTITRYPSIN
116, 5du3B, 0.8868, 2.08, 0.250, 377, 344, ACTIVE FORM OF HUMAN C1-INHIBITOR
117, 1by7A, 0.8865, 1.78, 0.325, 354, 338, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2. LOOP (66-98) DELETION MUTANT
118, 4rsqB, 0.8864, 2.19, 0.266, 355, 342, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
119, 5ce0A, 0.8861, 1.82, 0.373, 352, 338, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
120, 4robA, 0.8861, 2.21, 0.268, 356, 343, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
121, 5du3A, 0.8860, 2.08, 0.250, 378, 344, ACTIVE FORM OF HUMAN C1-INHIBITOR
122, 4rsqF, 0.8858, 2.10, 0.270, 353, 341, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
123, 6cj7A, 0.8854, 2.10, 0.283, 357, 343, CRYSTAL STRUCTURE OF MANDUCA SEXTA SERINE PROTEASE INHIBITOR (SERPIN)- 12 
124, 5duqA, 0.8853, 2.06, 0.248, 362, 343, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
125, 1attA, 0.8852, 2.34, 0.280, 420, 350, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
126, 4y3kB, 0.8851, 1.99, 0.238, 361, 341, STRUCTURE OF VASPIN MUTANT E379S
127, 1imvA, 0.8850, 2.25, 0.211, 375, 346, 2.85 A CRYSTAL STRUCTURE OF PEDF
128, 2hi9A, 0.8848, 2.05, 0.250, 356, 340, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
129, 1xqgB, 0.8846, 2.46, 0.268, 378, 351, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
130, 4dteB, 0.8840, 2.36, 0.261, 364, 349, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
131, 4rsqI, 0.8837, 2.21, 0.269, 356, 342, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
132, 1xqgA, 0.8835, 2.49, 0.268, 378, 351, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
133, 2r9yA, 0.8833, 2.10, 0.245, 365, 343, STRUCTURE OF ANTIPLASMIN
134, 5duqB, 0.8832, 2.09, 0.251, 365, 343, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
135, 4rsqJ, 0.8832, 2.22, 0.269, 355, 342, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
136, 1jtiB, 0.8831, 2.20, 0.280, 381, 346, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
137, 1xu8B, 0.8830, 2.61, 0.268, 373, 351, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
138, 1jtiA, 0.8830, 2.20, 0.280, 381, 346, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
139, 1oc0A, 0.8829, 2.39, 0.294, 364, 350, PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN
140, 4rsqD, 0.8828, 2.25, 0.269, 355, 342, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
141, 2hi9B, 0.8826, 2.03, 0.250, 354, 340, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
142, 4dteA, 0.8823, 2.38, 0.251, 374, 350, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
143, 1xu8A, 0.8819, 2.38, 0.267, 365, 348, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
144, 2ol2A, 0.8817, 1.99, 0.254, 360, 339, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
145, 1db2B, 0.8816, 2.33, 0.294, 362, 347, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
146, 4ro9A, 0.8815, 2.13, 0.268, 353, 340, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
147, 5brrI, 0.8814, 2.36, 0.301, 372, 349, MICHAELIS COMPLEX OF TPA-S195A:PAI-1
148, 1dvmD, 0.8811, 2.57, 0.297, 372, 350, ACTIVE FORM OF HUMAN PAI-1
149, 1xqjA, 0.8809, 2.51, 0.268, 378, 351, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP I 4 2 2
150, 1dvmA, 0.8807, 2.62, 0.299, 375, 351, ACTIVE FORM OF HUMAN PAI-1
151, 3pb1I, 0.8805, 2.68, 0.296, 375, 351, CRYSTAL STRUCTURE OF A MICHAELIS COMPLEX BETWEEN PLASMINOGEN ACTIVATOR INHIBITOR-1 AND UROKINASE-TYPE PLASMINOGEN ACTIVATOR
152, 4eb1I, 0.8799, 2.86, 0.276, 411, 355, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
153, 4rsqC, 0.8796, 2.18, 0.271, 354, 340, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
154, 3f5nC, 0.8787, 1.92, 0.339, 358, 336, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
155, 4robC, 0.8782, 2.18, 0.268, 351, 339, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
156, 1b3kA, 0.8780, 2.68, 0.302, 373, 351, PLASMINOGEN ACTIVATOR INHIBITOR-1
157, 1b3kC, 0.8779, 2.74, 0.301, 373, 352, PLASMINOGEN ACTIVATOR INHIBITOR-1
158, 3ndaA, 0.8772, 2.41, 0.319, 374, 348, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
159, 1dvmB, 0.8770, 2.57, 0.303, 365, 350, ACTIVE FORM OF HUMAN PAI-1
160, 4zk0A, 0.8763, 2.25, 0.316, 367, 345, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. HIGH PH STRUCTURE
161, 4zk3A, 0.8762, 2.41, 0.312, 366, 346, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. LOW PH STRUCTURE
162, 3q02A, 0.8760, 2.26, 0.299, 358, 344, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
163, 4g8oC, 0.8757, 2.53, 0.300, 367, 347, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
164, 3q03A, 0.8756, 2.27, 0.299, 360, 344, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
165, 4g8oD, 0.8755, 2.54, 0.297, 367, 347, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
166, 3ut3C, 0.8751, 2.52, 0.297, 368, 347, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
167, 2hi9C, 0.8751, 1.93, 0.251, 346, 335, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
168, 1kctA, 0.8739, 2.56, 0.283, 375, 350, ALPHA1-ANTITRYPSIN
169, 4g8rB, 0.8737, 2.60, 0.300, 368, 347, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
170, 3q03B, 0.8737, 2.47, 0.297, 364, 347, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
171, 3q02B, 0.8731, 2.40, 0.296, 362, 345, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
172, 4ic0A, 0.8727, 2.53, 0.298, 366, 346, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
173, 3ut3A, 0.8727, 2.52, 0.298, 367, 346, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
174, 3ut3D, 0.8726, 2.45, 0.298, 360, 346, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
175, 4p0fA, 0.8725, 2.25, 0.362, 369, 343, CLEAVED SERPIN 42DA (C 2 2 21)
176, 4ic0C, 0.8724, 2.53, 0.298, 366, 346, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
177, 3ut3B, 0.8723, 2.44, 0.301, 360, 346, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
178, 4ro9B, 0.8722, 2.13, 0.271, 348, 336, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
179, 1dvmC, 0.8721, 2.43, 0.301, 364, 346, ACTIVE FORM OF HUMAN PAI-1
180, 3zhaD, 0.8720, 2.58, 0.256, 368, 351, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
181, 3b9fI, 0.8710, 2.09, 0.254, 356, 338, 1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX
182, 4ic0D, 0.8707, 2.45, 0.296, 359, 345, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
183, 4c41A, 0.8695, 2.38, 0.238, 367, 345, CORTICOSTEROID-BINDING GLOBULIN WITH ENGINEERED DISULPHIDE BRIDGE BETWEEN RESIDUES 100 AND 236
184, 2ol2B, 0.8692, 1.92, 0.257, 343, 334, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
185, 4ic0B, 0.8689, 2.42, 0.297, 358, 344, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
186, 2vdxA, 0.8689, 2.36, 0.241, 366, 344, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
187, 4c49A, 0.8683, 2.40, 0.232, 367, 345, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
188, 2vdyB, 0.8672, 2.31, 0.243, 361, 342, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
189, 4c49B, 0.8671, 2.30, 0.234, 362, 342, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
190, 4g8oB, 0.8669, 2.51, 0.299, 359, 345, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
191, 1wz9B, 0.8668, 2.34, 0.279, 355, 341, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
192, 1b3kB, 0.8666, 2.46, 0.299, 358, 344, PLASMINOGEN ACTIVATOR INHIBITOR-1
193, 4g8oA, 0.8664, 2.52, 0.301, 359, 345, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
194, 1b3kD, 0.8664, 2.46, 0.302, 358, 344, PLASMINOGEN ACTIVATOR INHIBITOR-1
195, 4g8rA, 0.8661, 2.40, 0.300, 357, 343, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
196, 3zhaB, 0.8650, 2.55, 0.261, 364, 348, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
197, 4c49C, 0.8645, 2.44, 0.239, 363, 343, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
198, 3f5nE, 0.8638, 1.70, 0.354, 340, 328, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
199, 1atuA, 0.8638, 2.84, 0.284, 374, 352, UNCLEAVED ALPHA-1-ANTITRYPSIN
200, 2vdxB, 0.8632, 2.29, 0.244, 360, 340, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
201, 1a7cA, 0.8630, 2.59, 0.299, 364, 348, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE
202, 3ndaB, 0.8627, 2.57, 0.314, 372, 347, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
203, 2antL, 0.8623, 2.51, 0.285, 398, 344, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
204, 1br8L, 0.8621, 2.54, 0.285, 398, 344, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
205, 1e05L, 0.8616, 2.52, 0.285, 417, 344, PLASMA ALPHA ANTITHROMBIN-III
206, 5c98A, 0.8614, 2.60, 0.209, 359, 345, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
207, 2b4xL, 0.8609, 2.51, 0.282, 410, 344, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
208, 1dzgL, 0.8608, 2.52, 0.282, 409, 344, N135Q-S380C-ANTITHROMBIN-III
209, 3cvmA, 0.8607, 2.69, 0.299, 377, 348, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
210, 2vdyA, 0.8607, 2.40, 0.243, 361, 342, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
211, 2behL, 0.8607, 2.53, 0.285, 403, 344, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
212, 1lk6L, 0.8602, 2.56, 0.285, 406, 344, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
213, 1r1lL, 0.8601, 2.55, 0.285, 409, 344, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
214, 1e04L, 0.8600, 2.57, 0.288, 412, 344, PLASMA BETA ANTITHROMBIN-III
215, 1dzhL, 0.8599, 2.53, 0.282, 407, 344, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
216, 2hijL, 0.8597, 2.55, 0.285, 409, 344, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
217, 5ei0A, 0.8587, 2.68, 0.236, 372, 348, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
218, 3zhaQ, 0.8586, 2.74, 0.249, 365, 350, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
219, 1jvqL, 0.8586, 2.60, 0.285, 406, 344, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
220, 1antL, 0.8584, 2.48, 0.283, 392, 343, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
221, 3cvmB, 0.8582, 2.73, 0.299, 377, 348, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
222, 4eb1L, 0.8581, 2.61, 0.288, 392, 344, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
223, 1oyhL, 0.8581, 2.55, 0.282, 410, 344, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
224, 1sngA, 0.8580, 2.29, 0.213, 349, 334, STRUCTURE OF A THERMOPHILIC SERPIN IN THE NATIVE STATE
225, 3zhaL, 0.8577, 2.82, 0.245, 369, 351, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
226, 5c98B, 0.8572, 2.82, 0.207, 364, 348, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
227, 4au4G, 0.8565, 2.68, 0.267, 368, 348, CRYSTAL STRUCTURE OF HSP47
228, 3zhaC, 0.8561, 2.79, 0.246, 376, 349, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
229, 5ei0E, 0.8560, 2.67, 0.236, 371, 347, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
230, 1wz9A, 0.8559, 2.47, 0.274, 357, 340, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
231, 4au4F, 0.8558, 2.71, 0.264, 368, 348, CRYSTAL STRUCTURE OF HSP47
232, 4au4D, 0.8555, 2.69, 0.265, 366, 347, CRYSTAL STRUCTURE OF HSP47
233, 2arqA, 0.8553, 2.56, 0.322, 360, 342, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGDGGVMTGR-OH
234, 3zhaA, 0.8548, 2.80, 0.246, 380, 349, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
235, 4au4C, 0.8543, 2.80, 0.249, 370, 350, CRYSTAL STRUCTURE OF HSP47
236, 1azxL, 0.8531, 2.67, 0.285, 414, 344, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
237, 3eoxA, 0.8523, 2.71, 0.301, 370, 345, HIGH QUALITY STRUCTURE OF CLEAVED PAI-1-STAB
238, 4pywA, 0.8522, 2.65, 0.273, 362, 344, 1.92 ANGSTROM CRYSTAL STRUCTURE OF A1AT:TTAI TERNARY COMPLEX
239, 4ro9C, 0.8519, 1.98, 0.276, 336, 326, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
240, 2arrA, 0.8518, 2.67, 0.319, 358, 342, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGMGGVMTGR-OH
241, 1e03L, 0.8514, 2.69, 0.285, 423, 344, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
242, 1nq9L, 0.8499, 2.73, 0.285, 413, 344, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
243, 1jrrA, 0.8494, 2.64, 0.320, 357, 341, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP
244, 4r9iA, 0.8488, 2.61, 0.157, 378, 343, CRYSTAL STRUCTURE OF CYSTEINE PROTEINASE INHIBITOR SERPIN18 FROM BOMBYX MORI
245, 4au2D, 0.8487, 2.59, 0.263, 359, 342, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
246, 3zhaP, 0.8486, 2.88, 0.249, 373, 349, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
247, 2wy0C, 0.8485, 2.79, 0.164, 424, 347, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM WITH SPACE GROUP P6122
248, 4au2A, 0.8478, 2.82, 0.250, 367, 348, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
249, 3evjL, 0.8475, 2.80, 0.288, 417, 344, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
250, 3dlwA, 0.8469, 2.75, 0.304, 360, 339, ANTICHYMOTRYPSIN
251, 2wxyC, 0.8466, 2.84, 0.156, 419, 347, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE REDUCED FORM
252, 4au4E, 0.8463, 2.80, 0.251, 367, 347, CRYSTAL STRUCTURE OF HSP47
253, 4au4B, 0.8457, 2.88, 0.249, 368, 349, CRYSTAL STRUCTURE OF HSP47
254, 3stoA, 0.8455, 2.57, 0.252, 361, 337, SERPIN FROM THE TREMATODE SCHISTOSOMA HAEMATOBIUM
255, 4au4A, 0.8451, 2.76, 0.266, 366, 346, CRYSTAL STRUCTURE OF HSP47
256, 3zhaK, 0.8449, 2.93, 0.249, 374, 349, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
257, 4c49D, 0.8441, 2.43, 0.238, 356, 336, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
258, 4au3D, 0.8427, 2.76, 0.257, 359, 343, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
259, 4au2B, 0.8385, 2.59, 0.263, 354, 338, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
260, 1qmnA, 0.8372, 3.03, 0.314, 365, 341, ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP INSERTION)
261, 4aqhA, 0.8357, 2.94, 0.306, 382, 343, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
262, 5m3yA, 0.8355, 2.75, 0.152, 418, 342, CRYSTAL STRUCTURE OF HUMAN GLYCOSYLATED ANGIOTENSINOGEN
263, 2wxxC, 0.8326, 2.88, 0.162, 422, 345, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
264, 4aqhC, 0.8319, 3.00, 0.306, 382, 343, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
265, 4aqhB, 0.8317, 2.99, 0.306, 383, 343, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
266, 1athB, 0.8314, 2.60, 0.288, 362, 333, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
267, 2x0bH, 0.8309, 2.83, 0.140, 423, 342, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
268, 2x0bF, 0.8309, 2.83, 0.140, 423, 342, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
269, 2x0bD, 0.8309, 2.83, 0.140, 423, 342, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
270, 2x0bB, 0.8309, 2.83, 0.140, 423, 342, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
271, 4au3B, 0.8298, 2.77, 0.233, 351, 339, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
272, 2wxwA, 0.8294, 2.85, 0.146, 438, 342, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN
273, 3lw2A, 0.8290, 2.62, 0.285, 365, 333, MOUSE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
274, 2pefA, 0.8281, 2.93, 0.279, 366, 337, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE LATENT STATE
275, 2wxzA, 0.8279, 3.08, 0.153, 422, 346, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
276, 2wxxD, 0.8272, 2.96, 0.151, 411, 344, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
277, 5cdzA, 0.8270, 2.87, 0.384, 361, 336, CRYSTAL STRUCTURE OF CONSERPIN IN THE LATENT STATE
278, 4au3C, 0.8261, 3.02, 0.259, 357, 343, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
279, 4au3A, 0.8261, 2.91, 0.249, 354, 341, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
280, 2wxxA, 0.8248, 2.98, 0.166, 412, 344, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
281, 2wxxB, 0.8240, 3.05, 0.162, 428, 345, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
282, 2wxzC, 0.8213, 2.94, 0.155, 413, 341, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
283, 4kdsA, 0.8205, 2.84, 0.290, 370, 335, CRYSTAL STRUCTURE OF LATENT RAINBOW TROUT PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1)
284, 2wy1B, 0.8205, 3.01, 0.155, 417, 343, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
285, 2wy1A, 0.8205, 3.01, 0.155, 418, 343, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
286, 1c5gA, 0.8183, 3.25, 0.303, 379, 343, PLASMINOGEN ACTIVATOR INHIBITOR-1
287, 1iz2A, 0.8126, 3.00, 0.294, 371, 337, INTERACTIONS CAUSING THE KINETIC TRAP IN SERPIN PROTEIN FOLDING
288, 5om7A, 0.8124, 2.42, 0.309, 338, 320, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II: A DRUG- BINDING SERPIN FOR DOXORUBICIN 
289, 1dvnA, 0.8120, 3.30, 0.304, 379, 342, LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
290, 4afxA, 0.8118, 2.41, 0.246, 347, 321, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN I2 SPACE GROUP
291, 5om2A, 0.8108, 2.45, 0.309, 338, 320, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I1: A DRUG- BINDING SERPIN FOR DOXYCYCLINE 
292, 1lj5A, 0.8090, 3.26, 0.304, 379, 339, 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1)
293, 2oayA, 0.8083, 2.88, 0.264, 368, 330, CRYSTAL STRUCTURE OF LATENT HUMAN C1-INHIBITOR
294, 2v95A, 0.8067, 2.69, 0.193, 342, 327, STRUCTURE OF CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH CORTISOL
295, 2vh4A, 0.8057, 3.17, 0.278, 380, 335, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
296, 4ajuA, 0.8045, 2.52, 0.247, 349, 320, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN P41 SPACE GROUP
297, 4yiaA, 0.8042, 2.55, 0.254, 337, 319, STRUCTURAL MECHANISM OF HORMONE RELEASE IN THYROXINE BINDING GLOBULIN
298, 5m3xB, 0.8035, 2.96, 0.147, 387, 334, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
299, 4au2C, 0.8032, 2.51, 0.262, 338, 321, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
300, 2riwA, 0.8030, 2.55, 0.254, 337, 319, THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE
301, 5om3A, 0.8028, 2.59, 0.313, 335, 319, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I5: A MMP14- CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
302, 2xn5A, 0.8027, 2.59, 0.253, 341, 320, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH FUROSEMIDE
303, 2xn6A, 0.8026, 2.55, 0.254, 337, 319, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN
304, 2rivA, 0.8022, 2.64, 0.253, 339, 320, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN
305, 2xn7A, 0.8020, 2.64, 0.253, 339, 320, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN (T405-CF)
306, 2xn3A, 0.8019, 2.57, 0.254, 337, 319, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH MEFENAMIC ACID
307, 5m3xA, 0.8012, 2.95, 0.141, 383, 333, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
308, 1as4A, 0.7999, 2.54, 0.321, 336, 318, CLEAVED ANTICHYMOTRYPSIN A349R
309, 2h4qA, 0.7994, 2.68, 0.314, 352, 322, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE CLEAVED CONFORMATION
310, 2vh4B, 0.7985, 2.93, 0.287, 374, 327, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
311, 2achA, 0.7976, 2.58, 0.317, 337, 319, CRYSTAL STRUCTURE OF CLEAVED HUMAN ALPHA1-ANTICHYMOTRYPSIN AT 2.7 ANGSTROMS RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS
312, 6ftpA, 0.7961, 2.53, 0.306, 335, 317, CRYSTAL FORM 1 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
313, 2h4pA, 0.7959, 2.76, 0.319, 350, 323, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE CLEAVED CONFORMATION
314, 1hleA, 0.7958, 2.75, 0.324, 344, 321, CRYSTAL STRUCTURE OF CLEAVED EQUINE LEUCOCYTE ELASTASE INHIBITOR DETERMINED AT 1.95 ANGSTROMS RESOLUTION
315, 5om6A, 0.7946, 2.73, 0.308, 339, 321, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
316, 3caaA, 0.7926, 2.58, 0.316, 334, 316, CLEAVED ANTICHYMOTRYPSIN A347R
317, 5om5A, 0.7925, 2.60, 0.310, 338, 319, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO1: AN ALLOSTERICALLY TRIGGERED DRUG-BINDING SERPIN FOR DOXYCYCLINE 
318, 5om8A, 0.7893, 2.56, 0.312, 336, 317, CRYSTAL FORM 2 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
319, 5ncwA, 0.7890, 2.71, 0.252, 334, 317, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN (V367K/K368A MUTANT).
320, 4bb2A, 0.7880, 2.71, 0.225, 332, 316, CRYSTAL STRUCTURE OF CLEAVED CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH PROGESTERONE
321, 4caaA, 0.7863, 2.63, 0.324, 333, 315, CLEAVED ANTICHYMOTRYPSIN T345R
322, 3nddA, 0.7842, 2.76, 0.287, 335, 317, CLEAVED ANTITRYPSIN WITH P10 PRO AND P9-P6 ASP
323, 3ndfA, 0.7819, 2.68, 0.285, 336, 316, CLEAVED ANTITRYPSIN WITH P8-P6 ASP
324, 8apiA, 0.7814, 2.87, 0.279, 340, 319, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
325, 9apiA, 0.7805, 2.90, 0.279, 339, 319, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
326, 2d26A, 0.7795, 2.91, 0.289, 336, 318, ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX
327, 7apiA, 0.7794, 2.91, 0.279, 339, 319, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
328, 1d5sA, 0.7794, 2.91, 0.282, 334, 319, CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER
329, 9paiA, 0.7784, 3.11, 0.291, 346, 323, CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1
330, 5inwA, 0.7775, 2.70, 0.283, 335, 315, STRUCTURE OF REACTION LOOP CLEAVED LAMPREY ANGIOTENSINOGEN
331, 1ezxA, 0.7761, 2.88, 0.284, 335, 317, CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX
332, 5ncuA, 0.7757, 2.71, 0.256, 329, 312, STRUCTURE OF THE SUBTILISIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
333, 3t1pA, 0.7755, 2.87, 0.278, 371, 317, CRYSTAL STRUCTURE OF AN ALPHA-1-ANTITRYPSIN TRIMER
334, 5om6C, 0.7749, 2.72, 0.310, 335, 316, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
335, 5inwB, 0.7723, 2.71, 0.281, 331, 313, STRUCTURE OF REACTION LOOP CLEAVED LAMPREY ANGIOTENSINOGEN
336, 3f02B, 0.7722, 2.66, 0.332, 327, 310, CLEAVED HUMAN NEUROSERPIN
337, 1qmbA, 0.7718, 2.77, 0.286, 326, 315, CLEAVED ALPHA-1-ANTITRYPSIN POLYMER
338, 1lq8G, 0.7716, 2.81, 0.250, 330, 312, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
339, 1lq8A, 0.7700, 2.81, 0.250, 329, 312, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
340, 5nctA, 0.7693, 2.70, 0.256, 325, 309, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
341, 3dy0A, 0.7673, 2.78, 0.251, 327, 311, CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN
342, 1lq8C, 0.7653, 2.82, 0.251, 328, 311, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
343, 1lq8E, 0.7621, 2.92, 0.250, 329, 312, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
344, 2znhA, 0.7580, 2.48, 0.271, 408, 303, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
345, 2znhB, 0.7564, 2.58, 0.270, 412, 304, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
346, 3f02A, 0.7561, 2.78, 0.322, 322, 307, CLEAVED HUMAN NEUROSERPIN
347, 1mtpA, 0.7543, 2.79, 0.203, 320, 306, THE X-RAY CRYSTAL STRUCTURE OF A SERPIN FROM A THERMOPHILIC PROKARYOTE
348, 1c8oA, 0.7181, 2.60, 0.278, 300, 288, 2.9 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
349, 1f0cA, 0.6879, 2.74, 0.286, 297, 280, STRUCTURE OF THE VIRAL SERPIN CRMA
350, 1m93B, 0.5701, 2.91, 0.282, 245, 234, 1.65 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
351, 1jjoD, 0.5689, 2.47, 0.372, 244, 226, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
352, 1jjoC, 0.5689, 2.47, 0.372, 244, 226, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
